Ranitidine Hydrochloride

盐酸雷尼替丁

Report date: 2026/04/08 20:02:35
NME

Base Information

Drug NameRanitidine Hydrochloride
Drug Alias Name雷尼替丁盐酸盐ranitidineRanitidinum盐酸铋雷尼替丁盐酸雷尼尔丁 +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H2 receptor antagonists
TargetsHistamine H2 receptor
Therapy Area/IndicationshyperchlorhydriaHeartburnImmunologic Deficiency Syndromes +[12] 
Global Approved IndicationshyperchlorhydriaStomach UlcerDuodenal Ulcer +[4] 
Approved Indications in ChinahyperchlorhydriaStomach UlcerDuodenal Ulcer
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesEU +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesPai Holdings LLCJinghua Pharmaceutical Group Co LtdGsk Ltd
Inactive CompaniesC.H. Boehringer Sohn Ag & Co. KgJilin Provincial Institute Of Traditional Chinese MedicineGlaxo Wellcome Inc +[8] 
Active IndicationshyperchlorhydriaStomach UlcerDuodenal Ulcer +[4] 
Inactive IndicationsHeartburnImmunologic Deficiency SyndromesJob Syndrome +[8] 

Other Information

ATC CodeA02BA02
Related LinksWikipediaDrugBankKEGG